BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $228,119 | +12.3% | 5,007 | 0.0% | 0.08% | +10.3% |
| Q1 2023 | $203,084 | -38.5% | 5,007 | -22.7% | 0.07% | -42.4% |
| Q4 2022 | $330,031 | -5.4% | 6,475 | 0.0% | 0.12% | -9.9% |
| Q3 2022 | $349,000 | -16.1% | 6,475 | 0.0% | 0.13% | -8.4% |
| Q2 2022 | $416,000 | -17.1% | 6,475 | 0.0% | 0.14% | +0.7% |
| Q1 2022 | $502,000 | -14.8% | 6,475 | -5.6% | 0.14% | -14.5% |
| Q4 2021 | $589,000 | -1.0% | 6,861 | -7.2% | 0.17% | -6.2% |
| Q3 2021 | $595,000 | -10.5% | 7,395 | -10.5% | 0.18% | -9.2% |
| Q2 2021 | $665,000 | -17.3% | 8,263 | -13.3% | 0.20% | -24.7% |
| Q1 2021 | $804,000 | +1.1% | 9,527 | -3.9% | 0.26% | -4.1% |
| Q4 2020 | $795,000 | -0.3% | 9,912 | 0.0% | 0.27% | -12.1% |
| Q3 2020 | $797,000 | -6.6% | 9,912 | 0.0% | 0.31% | -13.3% |
| Q2 2020 | $853,000 | +12.1% | 9,912 | +5.7% | 0.35% | -11.9% |
| Q1 2020 | $761,000 | -2.9% | 9,378 | 0.0% | 0.40% | +11.7% |
| Q4 2019 | $784,000 | -9.0% | 9,378 | -4.9% | 0.36% | -18.2% |
| Q3 2019 | $862,000 | +2.7% | 9,860 | -3.8% | 0.44% | +2.6% |
| Q2 2019 | $839,000 | -2.1% | 10,246 | -2.8% | 0.43% | -1.8% |
| Q1 2019 | $857,000 | +23.5% | 10,546 | 0.0% | 0.44% | +7.1% |
| Q4 2018 | $694,000 | -14.6% | 10,546 | 0.0% | 0.41% | -4.4% |
| Q3 2018 | $813,000 | +4.5% | 10,546 | 0.0% | 0.43% | -7.0% |
| Q2 2018 | $778,000 | +13.4% | 10,546 | 0.0% | 0.46% | +9.0% |
| Q1 2018 | $686,000 | +0.6% | 10,546 | 0.0% | 0.42% | -0.5% |
| Q4 2017 | $682,000 | +3.0% | 10,546 | 0.0% | 0.42% | -3.6% |
| Q3 2017 | $662,000 | -3.5% | 10,546 | -6.9% | 0.44% | -4.1% |
| Q2 2017 | $686,000 | +13.0% | 11,325 | -3.3% | 0.46% | +5.0% |
| Q1 2017 | $607,000 | +5.9% | 11,711 | -9.4% | 0.44% | -5.0% |
| Q4 2016 | $573,000 | – | 12,927 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |